How many insider trades does FilingIQ track for AQST?

FilingIQ tracks 249 Form 4 insider transactions for AQST (Aquestive Therapeutics, Inc.), covering filings from Jul 24, 2018 onwards. 31 of those were filed in the last 90 days.

Are AQST insiders net buyers or net sellers?

Across the full Form 4 history for AQST, 34 transactions (14%) were open-market purchases and 27 (11%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does AQST insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is AQST in?

Aquestive Therapeutics, Inc. (AQST) is classified in the Healthcare sector, specifically Drug Manufacturers - Specialty & Generic, with a current market capitalisation of $516.68M.

AQST insider trading

NasdaqGM Healthcare

Aquestive Therapeutics, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

249

Last 90 days

Buys / sells

14% / 11%

Market cap

$516.68M

About Aquestive Therapeutics, Inc.

Aquestive Therapeutics, Inc. operates as a pharmaceutical company in the United States and internationally. It offers Libervant, a buccal soluble film formulation of diazepam for the treatment of seizures; Suboxone, a sublingual film formulation of buprenorphine and naloxone for the treatment of opioid dependence; EMYLIF, an oral film formulation of riluzole; ONDIF, an oral soluble film formulation of ondansetron; SYMPAZAN, an oral soluble film formulation of clobazam used for the treatment of seizures associated with a rare, intractable form of epilepsy; KYNMOBI, a sublingual film formulation of apomorphine; and AZSTARYS, an fda-approved, once-daily product for the treatment of ADHD in patients age 6 years or older. The company's proprietary pipeline products include Anaphylm, an epinephrine sublingual film, which is in phase 3 clinical trial for the emergency treatment of allergic reactions, including anaphylaxis; and AQST-108, a topical gel that is in phase 2 clinical trial for the treatment of alopecia areata. In addition, it develops PharmFilm technology for patients suffering from certain central nervous system disorders; and Adrenaverse, an epinephrine prodrug platform. The company was incorporated in 2004 and is headquartered in Warren, New Jersey.

Company website: www.aquestive.com

AQST insider activity at a glance

FilingIQ has scored 249 insider transactions for AQST since Jul 24, 2018. The most recent filing in our index is dated May 7, 2026.

Across the full history, 34 open-market purchases and 27 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on AQST insider trades is 54.9/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live AQST trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Top insiders trading AQST

Barber Daniel

5 trades · score 69.0

Frequently asked

How many insider trades does FilingIQ track for AQST?: FilingIQ tracks 249 Form 4 insider transactions for AQST (Aquestive Therapeutics, Inc.), covering filings from Jul 24, 2018 onwards. 31 of those were filed in the last 90 days.
Are AQST insiders net buyers or net sellers?: Across the full Form 4 history for AQST, 34 transactions (14%) were open-market purchases and 27 (11%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does AQST insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is AQST in?: Aquestive Therapeutics, Inc. (AQST) is classified in the Healthcare sector, specifically Drug Manufacturers - Specialty & Generic, with a current market capitalisation of $516.68M.

Methodology & sources

Every AQST insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.